Oncology

Despite numerous treatment advances, early detection, public education, and smoking cessation are the best bets.

The new study has found that the lymphedema monitoring technology, marketed by LymphaTech, can effectively detect early arm swelling associated with lymphedema in breast cancer patients.

Trastuzumab-dttb was first approved in January 2019 across all eligible indications, mainly adjuvant treatment of HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric cancer.

The growth of the pipeline has led to increases in insurance carriers’ specialty plan spend.

Statins, widely used to lower cholesterol and prevent heart disease, may guard against heart damage caused by certain breast cancer therapies.

“We’re pretty devastated,” said Jessica Harris, a friend of Rutter, in an interview with WFSB. “She beat cancer and lost the battle to coronavirus—it’s just crazy.”

Although preventive measures may be largely the same for patients with cancer during the COVID-19, the pandemic could result in difficult treatment decisions.

A new study shows that the advantages of digital breast tomosynthesis are maintained over multiple years and rounds of screening compared with digital mammography.

Kirollos Hanna, PharmD, BCPS, BCOP, explains antibody drug conjugates and their method of action. This video was filmed at the Hematology/Oncology Pharmacists Association 2020 Meeting in Tampa, Florida.

Illustrating how pharmacists improve the lives of others in the health environment, and using data to back that up are the 2 most necessary steps in gaining approval for a new hire.

New research shows targeting stromal cells may be an effective way of overcoming resistance to chemotherapy and radiation in patients with glioblastoma, a deadly brain cancer.

Cannabis is comprised of over 480 compounds and 70 distinct cannabinoids, but tetrahydrocannabinol (THC) and cannabidiol (CBD) are the 2 most commonly used.

The FDA has approved nivolumab plus ipilimumab injections for intravenous use to treat hepatocellular carcinoma in patients who have been previously treated with sorafenib.

Novel approaches such as telemedicine may be a way to reach rural patients with cancer, according to a panel discussion at the Hematology/Oncology Pharmacists Association 2020 Meeting

Lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients with cancer face specific barriers when seeking medical care, but pharmacists and other medical professionals can take specific steps to reduce the gaps in care.

Individuals with the highest mercury levels in their blood were 79% more likely to report having had a non-melanoma skin cancer than those with the lowest levels.

Due to the uniqueness of each disease state and motivations of each player in the market to capture revenue from the growing industry, there is an abundance of specialty pharmacy solutions available in the market.

Pharmacy Times will be on-site next week to provide coverage of the sessions, recaps of the panel discussions, and interviews with the experts.

Gilead has agreed to pay $95.50 per share in cash for Forty Seven Inc, adding the 5-year old biotechnology company to bolster its portfolio of oncology drugs.

A study offers evidence that chimeric antigen receptor T-cell therapy may not only extend patients’ survival, but also improve their quality of life after treatment.

AL101 is a potent, selective, injectable small molecule gamma secretase inhibitor and was granted Orphan Drug designation in May 2019 for the treatment of ACC.

Pharmacists should be aware of what drug repurposing is and how it occurs as due to the vast amount of opportunities that exist.

Melissa B. Armitage, PharmD, BCOP, a clinical pharmacist who works in breast oncology at the Moffitt Cancer Center in Tampa, Florida, discussed this disease's pathophysiology, natural progression, and risk factors.

A session on the use of biosimilars, a topic that many pharmacists identify to be of growing importance in their practices, concluded the 2019 Directions in Oncology Pharmacy conference.

PARP inhibitors are novel therapies with indication focused on ovarian cancer; however, new agents are being studied for other cancers as well.

With cases of melanoma increasing more rapidly than those of other malignancies (especially in men), no conference on oncology pharmacy would be complete without a session covering this topic and its expansion of treatment options.

Many people are unaware that acute myeloid leukemia (AML) is the leading cause of acute leukemia in adults.

Approximately 73,000 NEW cases of renal cell carcinoma (RCC) are expected to be diagnosed in 2019 in the United States, with up to 70% of these cases anticipated to be clear-cell subtype.